Azita Saleki-Gerhardt
CIK: 0001563545
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- May 6, 2026ENTG
ENTEGRIS INC
Award(A)Direct1.4K shares- - Feb 27, 2026ABBV
AbbVie Inc.
Tax Payment(F)Direct16.3K shares at avg. $232.08$3.8M - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct6.1K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct17K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct6.6K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct7.1K shares- - Aug 12, 2025ABBV
AbbVie Inc.
Exercise(M)Direct42.4K shares at avg. $54.86$2.3M - Aug 12, 2025ABBV
AbbVie Inc.
Sale(S)Direct42.4K shares at avg. $198.42$8.4M - Apr 23, 2025ENTG
ENTEGRIS INC
Award(A)Direct2.9K shares- - Feb 28, 2025ABBV
AbbVie Inc.
Tax Payment(F)Direct17.1K shares at avg. $205.02$3.5M - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct6.1K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct18K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct7.4K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct7.1K shares- - Sep 24, 2024ABBV
AbbVie Inc.
Gift(G)Direct25.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 6, 2026 |  ENTG ENTEGRIS INC | Award(A) | 1,412 | - | $0 | Direct |
| Feb 27, 2026 |  ABBV AbbVie Inc. | Tax Payment(F) | 16,309 | $232.08 | $3,784,993 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 6,058 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 17,041 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 6,638 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 7,074 | - | $0 | Direct |
| Aug 12, 2025 | ABBV AbbVie Inc. | Exercise(M) | 42,370 | $54.86 | $2,324,418 | Direct |
| Aug 12, 2025 | ABBV AbbVie Inc. | Sale(S) | 42,370 | $198.42 | $8,407,055 | Direct |
| Apr 23, 2025 | ENTG ENTEGRIS INC | Award(A) | 2,897 | - | - | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Tax Payment(F) | 17,056 | $205.02 | $3,496,821 | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 6,060 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 17,986 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 7,378 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 7,074 | - | - | Direct |
| Sep 24, 2024 | ABBV AbbVie Inc. | Gift(G) | 25,630 | - | $0 | Direct |
1-15 of 15 transactions
About SALEKI-GERHARDT AZITA
SALEKI-GERHARDT AZITA (SEC CIK 0001563545) files insider reports with the SEC as Director of ENTEGRIS INC (ENTG) and EVP, CHIEF OPERATIONS OFFICER of AbbVie Inc. (ABBV).
Signal8 holds 8 ownership filings by SALEKI-GERHARDT AZITA, all Form 4s, filed between Sep 30, 2024 and May 8, 2026. Those filings report 15 transactions, from Sep 24, 2024 to May 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SALEKI-GERHARDT AZITA's filings is in NORTH CHICAGO, IL.
Recent filings by SALEKI-GERHARDT AZITA
- May 6, 2026: Grant or award of ENTG shares (Form 4, code A).
- Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
- Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
- Aug 12, 2025: Option exercise of ABBV shares (Form 4, code M).
- Aug 12, 2025: Open-market sale of ABBV shares (Form 4, code S).
Other insiders filing for ENTEGRIS INC (ENTG)
- Reeder David, President & CEO
- Blachier Olivier, President, Materials Solutions
- Colella Joseph, SVP and General Counsel
- Rice Susan G., SVP, Global Human Resources
- LOY BERTRAND, Executive Chair
- BRUGGEWORTH ROBERT A, Director